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Summary
RNase L is an ankyrin repeat domain containing dual endoribonuclease-pseudokinase that is
activated by unusual 2′,5′-oligoadenylate (2-5A) second messengers and which impedes viral
infections in higher vertebrates. Despite its importance in interferon regulated antiviral innate
immunity, relatively little is known about its precise mechanism of action. Here, we present a
functional characterization of 2.5 Å and 3.25 Å X-ray crystal and small angle x-ray scattering
structures of RNase L bound to a natural 2-5A activator with and without ADP or the non-
hydrolysable ATP mimetic AMP-PNP. These studies reveal how recognition of 2-5A through
interactions with the ankyrin repeat domain and the pseudokinase domain together with nucleotide
binding, impose a rigid intertwined dimer configuration that is essential for RNase catalytic and anti-
viral functions. The involvement of the pseudokinase domain of RNase L in 2-5A sensing, nucleotide
© 2014 Elsevier Inc. All rights reserved.
#To whom correspondence should be addressed: Robert H. Silverman, silverr@ccf.org, 216 445-9650, Frank Sicheri,
sicheri@lunenfeld.ca, 416 586-8471.
*These co-authors were equal contributors.
Accession Number: The coordinates of RNase L have been deposited to the Protein Data Bank with accession codes 4O1O and 4O1P.
Supplemental Information: Supplemental Information includes 7 Figures, 2 Tables and Supplemental Experimental Procedures and can
be found with this article online at:
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Mol Cell. Author manuscript; available in PMC 2015 January 23.
Published in final edited form as:













binding, dimerization, and ribonuclease functions highlights the evolutionary adaptability of the
eukaryotic protein kinase fold.
Introduction
In higher vertebrates, RNase L is a principal mediator of the interferon (IFN)-inducible antiviral
state that can determine survival of animals infected with highly pathogenic viruses (Zhou et
al., 1993; Zhou et al., 1997). Virus infected cells produce and secrete type I IFNs that bind to
the cell surface receptor, IFNAR, initiating JAK-STAT signaling to many IFN stimulated genes
(ISG), including 2′,5′-oligoadenylate (2-5A) synthetase (OAS) genes [reviewed in (Kristiansen
et al., 2011; Stark et al., 1998)]. OAS1-3 proteins are pathogen recognition receptors for the
viral pathogen associated molecular pattern, double-stranded (ds) RNA [reviewed in
(Silverman, 2007)]. Once activated by viral dsRNA, OAS uses ATP to synthesize a series of
2-5A molecules consisting of p3A(2′p5′A)n, n≥2 (Kerr and Brown, 1978). The only well
established function of 2-5A is to activate RNase L. 2-5A binds to monomeric, inactive RNase
L causing it to dimerize into its active state resulting in cleavage of single-stranded viral and
cellular RNA, principally after UpU and UpA dinucleotides (Floyd-Smith et al., 1981;
Wreschner et al., 1981). The triadenylate form of 2-5A is the minimal active species, however,
longer 2′,5′-oligoadenylates, such as the tetraadenylate, retain the ability to activate RNase L
(Dong et al., 1994). Naturally occurring species of 2-5A contain three phosphoryl groups on
the 5′-OH (Kerr and Brown, 1978), although 5′-monophosphorylated 2-5A is capable of
activating human RNase L in vitro (Dong et al., 1994). RNase L contains, from its N- to C-
termini, an ankyrin repeat (ANK) domain, a pseudo protein kinase (PK) domain lacking
catalytic function (Dong and Silverman, 1999), and a ribonuclease (RNase) domain, the latter
two of which a fused module homologous to the dual kinase- ribonuclease enzyme IRE1, a
key effector of the unfolded protein response pathway (Walter and Ron, 2011).
Crystallographic analysis of a monomeric ANK domain fragment of human RNase L (Tanaka
et al., 2004), provided a first view of a subset of molecular interactions required for binding to
2-5A. Subsequent analysis of the complete ANK domain revealed how concerted binding of
2-5A to two ANK domains can mediate dimerization (Han et al., 2012). Whether the PK and
RNase domains also participate in 2-5A recognition and how 2-5A induces dimerization of the
ANK domain imposing a specific dimer configuration on other regions of RNase L remained
open questions. The function of the pseudo PK domain has remained largely uncharacterized
but early studies indicated a possible role for ADP or ATP binding in enzyme stabilization or
activation (Dong et al., 1994; Wreschner et al., 1982). In addition, a K392R mutation in the
kinase ATP binding site of human RNase L (corresponding to residue 390 in porcine RNase
L) resulted in greatly impaired RNase activity (Dong and Silverman, 1999). Lastly, the RNase
domain of RNase L shows sequence similarity to only the RNase domain of IRE1 (Korennykh
et al., 2009; Lee et al., 2008) and by inference, RNase L was predicted to share a common
catalytic mechanism regulated by the imposition of a precise dimer configuration (Lee et al.,
2008).
To uncover the molecular basis for the regulation of RNase L anti-viral function, we solved
the 2.5 Å and 3.25 Å X-ray crystal and small angle X-ray scattering solution structures of near
full length porcine RNase L bound to a natural 2-5A activator with and without the ATP
mimetic AMP-PNP. Together with mutational and functional studies performed in vitro and
in vivo, these studies shed light on how RNase L recognizes 2-5A through concerted
interactions involving the ANK domain and through an unexpected appendage to the pseudo
PK domain, and furthermore on how 2-5A recognition together with nucleotide binding to the
pseudo PK domain, facilitates the imposition of a specific dimer configuration required for
RNase catalytic function.
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X-ray crystal structure of RNase L in complex with 2-5A
We identified diffracting crystals for porcine (Sus scrofa) RNase L (residues 21 to 732) lacking
20 N-terminal and 11 C-terminal protease-labile residues dispensable for enzymatic function
(Dong and Silverman, 1997). Crystals with the same space group, unit cell dimensions and
crystal packing arrangement were grown with natural 5′-triphosphorylated, 2′,5′- triadenylate
activator (2′-5′)p3A3 in the presence and absence of the ATP analogue AMP-PNP. Structures
determined to 2.5 Å and 3.25 Å resolution respectively, revealed a near complete model of
RNase L lacking only one N-terminal residue, two C-terminal residues, eight residues
comprising the ANK domain-PK domain linker and an internal 15 residue flexible loop within
the RNase domain (see Table S1 for data collection and refinement statistics). Crystal packing
arrangements and representative unbiased electron density centered on the 2-5A and AMP-
PNP ligands are shown in Figure S1. A structure-based sequence alignment of RNase L and
for comparison the dual PK domain - RNase domain catalytic module of IRE1 is shown in
Figure S2.
Structure Overview
Since the structures of RNase L in the presence and absence of AMP-PNP were near identical
(RMSD = 0.5 Å), we focused our analysis and discussion on the higher resolution AMP-PNP
bound structure. Four protomers of RNase L in the crystal asymmetric unit associate to form
two identical (RMSD = 0.3 Å) non-crystallographic dimers with each dimer engaging 2 mole
equivalents of 2-5A and of AMP-PNP ligands (Figure 1). Easily recognized within each RNase
L protomer are the ANK, PK, and RNase domains. As observed in the isolated ANK domain
crystal structures of human RNase L (Han et al., 2012; Tanaka et al., 2004), the ANK domain
of porcine RNase L adopts a crescent-shaped structure consisting of a stack of nine ankyrin
repeats (Figure 1B), each possessing a characteristic loop–helix1–loop–helix2–loop
architecture. Situated between ANK repeats 5 and 6, lies a non-characteristic -helical element
(corresponding to residues 156 to 163) denoted α-AR8′ (Figure 1A and Figure S2). Largely
disordered in the isolated ANK domain structures, helix α-AR8′ features prominently in inter-
domain interactions.
The pseudo kinase domain
The pseudo PK domain possesses a bilobal fold with a smaller N-terminal lobe (N-lobe) and
a larger C-terminal lobe (C-lobe) (Figure 2A). The N-lobe consists of a canonical five strand
anti-parallel β-sheet (denoted β1 to β5) and flanking helix αC (Figure S2). Grafted onto this
common core, the first 36 ordered residues of the PK domain form a non-canonical appendage,
with loop (L1)-helix (αA)–loop (L2) topology, which features prominently in 2-5A activator
recognition and in inter-domain interactions. The PK C- lobe, which also deviates greatly from
canonicality, is comprised of a three strand antiparallel β-sheet (β5′, β7-β8), a two strand β-
sheet (β6, β9) and seven α-helices (αD-αI) (Figure S2). Positioned between β-strand nine and
helix αF (as shown for PKA in Figure 2B) are the expected positions of the activation segment,
helix αEF and the helix αEF-αF connecting loop, elements which serve phospho-regulatory
and phospho-acceptor recognition functions in prototypical protein kinases (Nolen et al.,
2004). In the RNase L structure, this entire region is absent and substituted by a four residue
shunt, whose structure enables a non-standard position of a split helix αG, an element also
normally implicated in PK substrate recognition (Brennan et al., 2011; Dar et al., 2005). Other
distinguishing features of the PK C-lobe include uncommon substitutions at PK conserved
positions Gln484, Gln481, and Asp502 (Lys, Arg, and Gly residues in IRE1 respectively)
(Figure 2C). Together, these unconventional features of the kinase C-lobe likely account for
the incompetence of RNase L as a PK enzyme (Dong and Silverman, 1999).
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However, suggesting a critical role for nucleotide binding in the overall biological function of
RNase L, a fully ordered AMP-PNP molecule is found coordinated by a full complement of
PK invariant residues, namely, Asp482 (catalytic base), Asn487 (Mg2+ coordination), Asp500
(Mg2+ coordination), Lys390 (phosphate coordination), Glu402 (salt contact with Lys390) and
Ala388 (contact with adenine base), within the kinase inter-lobe cleft (Figure 2C). The
uncommon substitution of Gly for Asp at position 502 is notable for contributing additional
interactions to a magnesium ion, which tethers the γ-phosphate of AMP-PNP (Figure 2C). The
binding of AMP-PNP gives rise to a rigid closed conformation of the PK domain as evidenced
by intact catalytic and regulatory spines (Figure 2D), features reflective of the active state of
protein kinases (Kornev et al., 2008). The absence of nucleotide in the AMP-PNP free structure
notably disrupts the integrity of the catalytic spine and leaves the kinase C-lobe relatively
untethered from the N-lobe.
The RNase domain
Extending as a rigid protrusion from PK C-lobe is the RNase domain consisting of nine α-
helices (denoted α1, α1′, α2-α8 – Figure 1A,C) with a 14-residue disordered sequence
(residues 646 to 659, harboring a 12 residue porcine specific insertion) between helices α3 and
α4. Centered on helix α4 of each protomer at the base of a deep cleft formed by the dimerization
of two RNase domains lies the ribonuclease active site with two copies composed in cis of an
invariant tetrad consisting of Tyr663, Arg 675, Asn676, and His680 side chains and the
conserved basic side chain of Lys672. Consistent with a shared catalytic mechanism for
phosphodiester bond cleavage inferred originally from comparisons to tRNA ribonuclease
(Lee et al., 2008; Xue et al., 2006), the catalytic residues of RNase L adopt conformations and
placements highly similar to those adopted by the corresponding residues of IRE1 (Figure 1C).
In contrast, residues composing the surrounding solvent exposed surface are completely
divergent across paralogues with RNase L also possessing a unique helical insert (helix α1′)
lining the outermost edge of the catalytic cleft. This divergence of structure may account for
the distinct RNA substrate repertoires of RNase L and IRE1.
Dimer configuration of RNase L
The dimer configuration of full length RNase L arises from the intertwining of two promoters
through a 155° twisting action across the ANK domain-PK domain junction, which gives rise
to the appearance of an exchange of ANK and PK domains between protomers. Cross protomer
contacts within the dimer are vastly greater than typical homodimers (Jones and Thornton,
1996) (total buried surface area = 7894/7102 Å2, including/excluding 2-5A contacts,
respectively) (Figures S2, S3), and consist of 1) the antiparallel interaction of two ANK
domains, 2) the parallel back-to-back interaction of the dual pseudo PK domain-RNase domain
modules, 3) cross protomer interaction between the ANK and pseudo PK domains, and 4)
coordinated binding of two 2-5A activators, each engaging a composite binding pocket
involving two ANK domains and the N-lobe of one PK domain.
Dimerization of the ANK domain is facilitated by a head-to-tail arrangement with concave
surfaces facing inwards (SA contact without 2-5A = 795 Å2) (Figure 1, Figures S2, S3). In
brief, ANK domain dimerization is mediated by the reciprocal interaction of ANK repeats 1
to 4 of one protomer with ANK repeat 9 of a second protomer at either end of the crescent
shaped structure, similar to the interaction mode uncovered for the isolated human ANK
domain bound to a synthetic 2-5A activator (RMSD between dimers = 2.1Å, PDBID = 4G8L).
Back-to-back interaction of the dual pseudo PK domain–RNase domain module
Dimerization of the dual pseudo PK domain-RNase domain module involves discontinuous
contacts between the two kinase N-lobes (surface area = 1478 Å2) and between the two RNase
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domains (surface area = 795 Å2) (Figure 3A, Figures S2, S3). Engagement of these two surfaces
is coordinated by the rigidly fused junction between the PK C-lobe and the RNase domain
arising from a contiguous hydrophobic core (Figure S4A), and by the binding of AMP-PNP
to the pseudo PK active site, which is predicted to constrain the inherent inter-lobe flexibility
of the PK domain to a single closed conformation (Masterson et al., 2011). Although only three
(Tyr419, Arg675, and His680) of 27 back-to-back dimer contact residues on each protomer
are conserved across paralogues (Figure S2), the back-to-back dimer configuration of RNase
L is highly similar (difference of 25°) to that adopted by yeast IRE1 (Figure S4A). Back-to-
back dimer contacts are primarily polar in nature and include a reciprocal salt bridge between
Glu383 and Arg410 in the kinase N-lobes and between Lys603 and Glu683 and between
Arg675 and Glu679 in the RNase domains (Figure 3A insets). Beyond this back-to-back dimer
arrangement, no other packing arrangement of RNase L in the crystal environment bears
resemblance to the helical polymer arrangement uncovered for IRE1 (Figure S1B-D).
Kinase domain - ANK domain contacts
Excluding the covalent link mediated by the eight residue disordered linker sequence, only a
tenuous pi-stacking interaction (buried surface = 78.2 Å2) between Arg308 and Trp352 links
the ANK and PK domains within each protomer (Figure 3, Figure S4B). In contrast, inter-
protomer interactions between PK and ANK domains within the dimer are extensive (buried
surface = 1588 Å2) (Figure 3B, Figures S2,S3). One set of interactions is mediated by the loop
regions following ANK repeats 1, 2, 4, 5, 6 and 7 and by helix α-AR8′. These elements contact
the top surface of the PK N-lobe with helix α-AR8′ engaging the G-rich loop of the PK domain
through a hydrophobic interaction between ANKIle162 and PKCys427 and a salt interaction
between ANKAsp158 and PKLys368. A second constellation of interactions is mediated by the
non-canonical appendage of the PK N-lobe, which engages the loop regions linking ANK
repeats 1-2 and 2-3. Included are three centered salt bridges between PKAsp364, ANKArg88,
and PKGlu366 and between PKArg350, ANKGlu55, and PKHis347, and a hydrophobic interaction
between ANKTrp58, PKIle351 and PKPhe362. A final set of interactions is mediated by the loop
regions linking ANK repeats 5-6, 6-7, 7-8, which form a constellation of charge complementary
interactions with the forward projecting end of PK helix αC and the β4-β5 linker, notably
between ANKArg 269 and PKGlu394.
The 2-5A binding site
The RNase L dimer engages two 2-5A activator molecules through symmetric pincer-like
mechanisms with each 2-5A molecule binding to a composite channel composed by the two
antiparallel aligned ANK domains and one PK domain (Figure 4A). The channel mouth
oriented inwards to a large internal cavity between RNase L protomers engages the tri-
phosphate moieties of Adenine 1 (Figure 4B), while the channel mouth oriented outwards to
solvent, accommodates the untethered end of activators of length greater than 3 adenine
residues (Figure 4A). Remarkably, within the tight confine of the channel center, virtually
every functional group of 2-5A is engaged in molecular interactions with RNase L.
Contacts with the two ANK domains bury 711 Å2 of the 1167 Å2 total surface area of 2-5A
and are similar overall to the contacts uncovered for a synthetic, mono-phosphate 2-5A
analogue in isolated ANK domain structures (Han et al., 2012; Tanaka et al., 2004). Subtle
differences in binding mode include a flip of the Adenine 3 base (Figure S5) and the
repositioning of the ANKArg308 side chain to capture a pi stacking interaction with PKTrp352
to form a clamp around the Adenine 3 ribose ring (Figure 4A). ANK repeats 1 to 6 of one
protomer make extensive (SA = 529 Å2) contact to the back side of all three adenine residues
while ANK repeat nine of the second protomer makes focused contacts (SA=182 Å2) with the
phosphate, sugar, and base of Adenine 3. Novel PK domain contacts covering 156 Å2 of 2-5A
are mediated primarily by L2 of the PK N-lobe appendage, with the beta and gamma phosphates
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of Adenosine 1 coordinated by a bifurcated salt interaction with the Lys164 side chain, which
in turn is coordinated by a salt interaction with Asp424 in the β4-β5 linker of the PK domain
(the latter is visible in Figure 3B). Lastly, the phosphate moiety linking Adenine 1 and Adenine
2 is coordinated by a salt interaction with Arg353 in the PK N-lobe appendage, and by van der
Waals contacts with adjacent Pro354, Ile363 and Phe362 side chains.
Structure guided mutational and in vitro functional analyses of RNase L
To probe the functional interplay between ANK, PK and RNase domains and the importance
of specific contacts, we pursued functional analyses of wild type (WT) RNase L and a
comprehensive panel of structure guided mutants (Figure 5, Figures S6, S7). We first
investigated the effect of ligand binding on the oligomerization status of WT enzyme in solution
using velocity analytical ultra centrifugation (Figure S6A). RNase L alone and in the presence
of AMP-PNP was a monomer over the 0.5 to 10 μM protein concentration range tested. In the
presence of 2-5A activator alone or with both 2-5A and AMP-PNP, RNase L was a dimer.
These results with porcine RNase L are consistent with the behavior of human RNase L (Cole
et al., 1997). Using fluorescein labeled RNase L, which enabled AUC analyses at nanomolar
protein concentrations, we observed that AMP-PNP had no significant effect on the ability of
RNase L to dimerize when already bound to 2-5A (Figure S6B). Using surface plasmon
resonance with biotin labeled 2-5A immobilized onto streptavidin sensor chips, we assessed
the relative binding affinity of full length versus an ANK domain only fragment of RNase L.
Consistent with the PK domain contributing direct contacts to 2-5A, full length RNase L bound
to 2-5A with ∼7 fold higher affinity than the isolated ANK domain (57 ± 16 nM versus 376
± 10 nM, respectively) (Figure 5A). In the case of full length RNase L, the presence of ATP
had no significant effect on the ability to bind 2-5A (Figure 5A, Figure S7A).
We next assessed the effect of ligand binding on the RNase activity of WT enzyme at 1.6 nM
concentration. In the absence of both or either of 2-5A and nucleotide ligand, no RNase activity
was detected, whereas in the presence of both ligands robust RNase activity was observed
(Figure 5B). We attribute the unanticipated strict dependency of RNase L RNase function on
nucleotide (Dong et al., 1994; Wreschner et al., 1982) to the purity of our protein preparations
(see methods). We also investigated the ability of RNase L to discriminate between nucleotides
since the RNase function of yeast IRE1 responds more potently to ADP than to ATP (Sidrauski
and Walter, 1997). We found that ATP, ADP and to a slight lesser degree, the non-hydrolysable
analog AMP-PNP, all potentiated RNase function (Figure 5B). Consistent with these
observations, mutation of ATP coordinating residues in RNaseL that markedly reduced
nucleotide binding (Figure 5C) also caused a major impairment to RNase enzyme function
(Figure 5D). This impairment could be partially offset for some mutants by higher nucleotide
concentration (Figure S7B). Consistent with the corollary finding, we observed that 2-5A did
not potentiate RNase L binding to nucleotide (Figure S7C).
Highlighting the functional importance of the parallel back-to-back dimer configuration of the
dual PK domain-RNase domain module, single or double mutations in the kinase domain
(Arg410Glu) or in the RNase domain (Arg675Glu, Glu679Arg, Arg675Glu/Glu679Arg)
greatly impaired RNase activity (Figure 5E). Notably, these adverse effects were comparable
to the loss of function displayed by the RNase catalytic tetrad mutant His680Ala (Figure 5F).
Similarly, mutation of the sole cis interaction site between ANK and PK domains (Arg308Ala
or Trp352Ala) caused great to intermediate loss of RNase function, respectively (Figure 5G).
The difference in severity for the two mutations may in part reflect the different roles that each
position also plays in directly contacting 2-5A (Figure 4). Disruption of the ANK domain - PK
domain interaction in trans by the single charge reversal substitutions Asp158Lys or
Lys368Asp, by the double substitution Asp158Lys/Lys368Asp or by deletion of helix aAR8′
(Δ156-166) also potently diminished RNase activity (Figure 5G). Lastly, Tyr310Ala,
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Lys164Glu and Arg353Glu mutations affecting 2-5A contacts with each of the two ANK
domains, and the PK domain, respectively, also perturbed RNase function (Figure 5H). Since
all RNase L mutants tested appeared properly folded as assessed by elution volume during
purification by size exclusion chromatography (data not shown), these in vitro functional
studies support the notion that the dimer configuration visualized in a crystal environment
reflects a functionally relevant form of RNase L in solution.
Impact of RNase L mutagenesis on ribonuclease activity in intact cells
To determine the effects of different mutations on enzyme activity in intact cells, HeLa-M cells
deficient in endogeneous RNase L were used (Xiang et al., 2003). WT or mutant forms of
porcine RNase L were transfected into HeLa-M cells for 24 hrs prior to transfecting with the
synthetic double-stranded RNA, poly(rI):poly(rC) (pIC) for an additional 3 hrs. When
introduced into cells, pIC activates OAS causing production and accumulation of 2-5A, and
activation of RNase L (Zhao et al., 2012). To monitor RNase L activity in intact cells, total
cellular RNA was isolated and separated on RNA chips (Agilent) (Xiang et al., 2003)(Figure
6A,B upper panels). The rRNA remained intact in control HeLa-M cells transfected with
empty vector following by pIC (Figure 6A,B, lane 1). In contrast, WT porcine RNase L
expressed in HeLa-M cells was strongly activated in response to pIC as determined by
monitoring highly specific and characteristic discrete cleavage products of 28S and 18S rRNA
from ribosomes (Silverman et al., 1983)(Figure 6A,B, compare lanes 2 & 3 without and with
pIC, respectively). Mutant RNase L lacking residues 156-166, an ANK segment interacting
with both 2-5A and the PK domain, lacked ribonuclease activity (Figure 6A, lane 4). The
Lys164Glu mutation of the binding site for natural 2-5A (through its beta and gamma
phosphoryl groups), showed reduced ribonuclease activity (Figure 6A, lane 5). Mutant
Tyr310Ala in the ANK 2-5A binding site was inactive, consistent with a prior report (Han et
al., 2012) (Figure 6A, lane 6). Arg410Glu in the PK:PK interface was also defective for
ribonuclease activity (Figure 6A, lane 7). Lys603Glu in the RNase:RNase interface had
reduced activity (Figure 6A, lane 8). RNase domain mutants Lys672Ala, Arg675Glu and
Glu679Arg were all defective (Figure 6A, lanes 9-11). ANK Mutation Asp158Lys, a residue
that forms a salt bridge to Lys368 in the PK domain, had reduced activity whereas ribonuclease
activity in the double compensatory mutant Asp158Lys-Lys368Glu, that regenerates the salt
bridge, was partially restored (Figure 6A, lanes 12 & 13). The latter result supports the
functionality of the ANK:PK domain interface although a partial recovery of function was not
observed for a similar Asp158Lys-Lys368Asp mutant in our in vitro analysis. Five mutations
in the ATP binding site of the PK domain were also evaluated for ribonuclease activity in intact
cells (Figure 6B). Mutants Ala388Phe, Asp482Ala, Asn487Ala, Asp500Ala and to a lesser
degree Glu402Ala, all showed reduced activity (Figure 6B, lanes 4-8). Expression of the WT
and the various mutant forms of porcine RNase L in HeLa-M cells occurred at similar levels
as determined in Western blots (Figure 6A,B, lower panels).
Effect of RNase L mutagenesis on viral infections
To determine if select mutations affect viral infections, WT or mutant forms of RNase L were
expressed in HeLa-M cells followed by infection at an moi of 0.01 with the picornavirus,
encephalomyocarditis virus (EMCV) (Hoskins and Sanders, 1957). At 14 hrs post infection,
cellular supernatants containing progeny virus were collected and titered by plaque assays on
monolayers of L929 indicator cells to determine viral yields. Expression levels of the WT and
different mutant RNase L proteins in the HeLa-M cells were similar as determined by Western
blotting (Figure 6A,B, and data not shown). WT RNase L reduced viral growth by about 12-
fold (Figure 6C). In contrast, D156-166 (a segment in ANK that contacts both 2-5A and the
PK domain), K164E (the binding site for natural 2-5A through its beta and gamma phosphoryl
groups), Arg410Glu (PK:PK interface) and Lys603Glu (RNase:RNase interface) were either
not inhibitory to viral growth, or minimally inhibitory, indicating these amino acid residues
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are essential for the antiviral activity of RNase L. These findings validate key features of the
dimeric RNase L structure in the context of an ongoing virus infection. In addition, no
significant inhibition of viral replication was obtained with ATP binding site mutants
Ala388Phe and Asp500Ala. However ATP-binding site mutants Glu402Ala, Asp482Ala, and
Asn487Ala retained a reduced ability to suppress viral replication when compared to WT
RNase L (Figure 6D).
Small angle X-ray scattering analysis of RNase L
To investigate the effect of nucleotide binding on the structure of RNase L in solution free of
confounding crystal-packing interactions, we employed small angle X-ray scattering (SAXS)
analyses. The Rg and Dmax derived for the scattering data for RNase L bound to 2-5A was
consistent with those expected from the crystal structure (see Table S2 for data collection
parameters). The SAXS envelope resulting from ten independently generated ab initio models
resulted in an elongated envelope with two distinct volumes. Superimposition of the crystal
structure of RNase L onto this envelope using the supcomb program revealed that the ankyrin
repeat domains and kinase N-lobes readily fit in the larger volume of the envelope and the
kinase C-lobes and RNase domains fit in the smaller volume (Figure 7A) (Kozin, 2001). In
good agreement, the Porod calculated molecular weight (195 kDa) is consistent with RNase L
existing as a dimer in solution. We then collected SAXS data for RNase L bound to 2-5A in
the presence of ADP and found the sample had smaller Rg and Dmax values (Table S2). The
averaged SAXS envelope for this sample was also elongated but smaller in overall volume.
Superimposition of the X-ray crystal structure of RNase L onto this envelope revealed a
tightening of volume along the dimerization axis most pronounced in the region corresponding
to the kinase C-lobe and RNase domains. These results are consistent with ADP causing a
restriction of motion between the two protein kinase lobes.
Discussion
The dimeric structure of RNase L in a complex with 2-5A and AMP-PNP provides mechanistic
insight into a fundamental molecular event in antiviral innate immunity, activation of RNase
L. The presented results are consistent with the following model for RNase L regulation and
function (Figure 7B). In the absence of stimuli, RNase L is a catalytically incompetent
monomer. In response to the binding of 2-5A ligands to composite binding channels involving
two ANK domains and one PK domain and to the binding of nucleotide to the PK active site,
full length RNase L dimerizes into a single rigid body that juxtaposes the two dual PK domain-
RNase domain modules in a parallel back-to-back configuration. Dimerization of the RNase
domain composes the RNase active site enabling the cleavage of RNA substrates to mediate
an antiviral response.
The RNase L regulatory model displays interesting parallels to that of IRE1, the sole protein
in eukaryotes to share a homologous dual PK–RNase domain module. In place of an ANK
domain, IRE1 possesses an endoplasmic reticulum (ER) resident luminal domain, which allows
it to sense the accumulation of toxic misfolded proteins. The detection of misfolded protein
transitions the ER luminal domain from low (n = 1 or 2) to high (n ≥ 2) stoichiometric oligomers
(Credle et al., 2005; Kimata et al., 2007). Unlike RNase L, the dual PK-RNase domain module
of IRE1 plays no role in the direct sensing of upstream activating stimuli, and indeed the sensor
and catalytic halves of IRE1 reside in separate organelle compartments, a feature which
necessitates a less direct and precise mechanism for propagating dimerization/oligomerization
signals. Lastly, the ability of the PK domain of RNase L to participate in stimuli sensing is
supported by the evolution of a unique N-terminal lobe appendage, not present in IRE1.
As a bona fide protein kinase, IRE1 also exploits its phospho-transfer function for auto
regulation (Shamu and Walter, 1996). Oligomerization of the ER luminal domain induces the
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close approach of cytoplasmic domains allowing trans auto-phosphorylation on sites within
the PK activation segment, a modification integral to the ability of the dual PK-RNase domain
module to sample a productive back-to-back dimer orientation (Lee et al., 2008). RNase L in
contrast, lacks both the infrastructure to support phospho-transfer function and also the
infrastructure (namely an activation segment harboring phospho- acceptor sites) to respond to
auto-phosphorylation. In this respect, RNaseL appears to have de-evolved to a structure akin
to that of primitive atypical protein kinases such as Rio1 and Bud32 (Laronde-Leblanc et al.,
2005; Mao et al., 2008), which are similarly lacking in canonical C-lobe features. Despite a
loss of phospho-transfer function, the ATP binding function of RNase L like that of IRE1 is
preserved, enabling the enforcement of a closed conformation of the PK domain required to
assemble a dimeric and functional RNase module (Lee et al., 2008).
The ability of IRE1 dimers to assemble into higher order oligomers provides an additional level
of control to promote RNase activity beyond that of minimal dimers (Korennykh et al.,
2009). While a highly cooperative (hill coefficient >4) dependence of RNase activity on
enzyme concentration was interpreted to reflect RNase L also acting as a higher order oligomer
(Han et al., 2012), we see no evidence of oligomer formation even at the high protein
concentrations employed in our analytical ultracentrifugation and SAXS analyses. Instead, we
reason that this behavior may be a manifestation of the dependence of RNase function on
dimerization and the coordinated binding of four (two 2-5A and two nucleotide) ligands.
IRE1 may act as a sensor of energy levels by virtue that its RNase activity is stimulated more
greatly by ADP than ATP (Sidrauski and Walter, 1997). This characteristic is not shared by
RNase L. Since total cellular ATP/ADP levels are generally high (3-5 mM) relative to the high
affinity of RNase L for ATP (0.6-1.2 μM), and are tightly regulated to remain constant, they
would be constitutively available for binding to the PK domain of RNase L. These properties
likely account for our observation that some ATP binding site mutants of RNase L that display
near complete impairment of RNase function in vitro at low ATP concentration display
significant residual function in cells. It is thus likely that the RNase function of RNase L is
regulated primarily by 2-5A levels. However it is conceivable that as yet undefined events or
factors such as post translational modifications, cellular or viral protein products, or small
molecules influence RNase function by modulating the ability of RNase L to interact with
nucleotide.
Prior studies have shown that RNase L is a potent inhibitor of viral infections that can be
essential for controlling viral pathogenesis, for instance as shown for viral hepatitis caused by
a murine coronavirus, MHV (Zhao et al., 2012). While a number of different RNA and DNA
viruses are susceptible to RNase L [reviewed in (Silverman, 2007)], some viruses have acquired
or evolved genes that antagonize the OAS-RNase L pathway at different levels, including
preventing OAS activation by sequestering dsRNA (Xiang et al., 2002), degrading 2-5A
(Zhang et al., 2013; Zhao et al., 2012), or directly inhibiting RNase L (Sorgeloos et al., 2013;
Townsend et al., 2008). Viral antagonism of the OAS-RNase L pathway emphasizes the threat
to the virus imposed by RNase L. Activation of RNase L also has profound effects on the cell
by regulating innate immune signaling (Malathi et al., 2007), autophagy (Chakrabarti et al.,
2012; Siddiqui and Malathi, 2012) and apoptosis (Castelli et al., 1998; Castelli et al., 1997;
Zhou et al., 1997). In addition, some human genetic studies have suggested that RNase L gene
variants influence risk for different types of cancer, including hereditary prostate cancer
(Carpten et al., 2002), hereditary non-polyposis colorectal cancer (Kruger et al., 2005), and
breast cancer (Madsen et al., 2008). A better understanding of RNase L activation at a molecular
level may provide insight into these different facets of RNase L biology. Indeed, in these studies
we show that the PK-PK interface, RNase-RNase interface, and ANK and pseudo-PK domains
that interact with 2-5A are all essential for the antiviral activity of RNase L.
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Protein expression, crystallization and structure determination
Wild type and mutant Sus scrofa RNase L proteins (residue 21 to 732 for crystallization studies
and residues 1 to 743 for SAXS and biochemical studies) were expressed in Escherichia coli
as TEV-cleavable GST fusions and purified by glutathione affinity, TEV cleavage, anion
exchange and finally size exclusion chromatography. All crystals were grown at 20 °C in
hanging drops by mixing one volume of protein solution with one volume of precipitant
solution. See Supplemental Information for details on expression plasmids, protein expression
and purification, 2-5A synthesis, protein concentrations, precipitant solutions, cryoprotectants,
and data collection and structure determination methodologies.
Analytical ultracentrifugation
Sedimentation velocity analytical ultracentrifugation was performed using unlabelled or
fluorescein labelled RNase L proteins with a Beckman ProteomeLab XL-I at 42,000 rpm with
either refractive index or fluorescence (Aviv Biomedical Inc.) detector system. See
Supplementary Information for details of protein preparation, experimental conditions and data
analysis methods.
In vitro RNA cleavage assays
Methods are as described previously (Thakur et al., 2005) with minor deviations described in
Supplementary Information.
2-5A binding analysis using surface plasmon resonance (SPR)
SPR studies were performed using a Biacore3000 (Piscataway, NJ) instrument, streptavidin
chips (Biacore SA BR-1003-98), and biotin-labeled 2-5A. See supplementary Information for
2-5A derivatization with biotin and experimental details. Sensograms were analyzed with the
BIAevaluation version 3.0.
In vitro ATP binding assay
ATP binding was determined by fluorescence polarization using BODIPY FL ATP-γ-S (25
nM, Molecular Probes Inc., USA) and titrating in WT RNase L or mutants in a buffer containing
25 mM HEPES, 50 mM NaCl, 1 mM DTT, 0.01% Brij 35, +/- 3 μM 2-5A, in a total reaction
volume of 25 μL. Polarization was measured on an HT analyst (ex:em, 485 nM:535 nM,
Molecular Devices, USA) and results analyzed in Graphpad Prism.
Cell Based RNA cleavage assay
The cell based assay for RNase L activity was performed as described previously (Carpten et
al., 2002) with minor modifications described in Supplementary Information.
In vivo EMCV assay
HeLa-M cells (1×105 cells per well in 12-well plates) were transiently transfected using
lipofectamine 2000 (LifeTechnologies) with 0.6 μg/ml of plasmid pCS2 containing WT or
mutant porcine RNase L cDNA for 20 hrs. Media was replaced 6 hrs before infection with
EMCV (Hoskins and Sanders, 1957) at an moi of 0.01 in serum free media for 1 hr. Cells were
washed and placed in complete media plus fetal bovine sera. At 14 hrs post-infection, media
contain virus was harvested and viral titers determined by plaque assay on L929 cells.
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The scattering data for RNase L with ADP and 2-5A and RNaseL/2-5A samples were collected
on a BioSAXS-1000 detector with MicroMax-007HF X-ray generator. Data collection and
processing details are provided in Supplementary Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Structural basis for RNase L regulation by 2-5A and nucleotide (ADP or ATP)
binding.
• Recognition of 2-5A is mediated by both ankyrin repeat and protein kinase
domains
• Nucleotide enforces a closed conformation of the kinase domain
• Nucleotide binding to the pseudo kinase domain is essential for RNA cleavage
function
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Figure 1. Crystal structure of RNase L
(A) Ribbons representation of the RNase L dimer. 2-5A and AMP-PNP ligands are shown as
sticks.
(B) Top view of the RNase L dimer orientation shown in (A).
(C) Bottom view of the RNase L dimer orientation shown in (A). Left, ribbons and surface
representation. Inset, zoom in view of RNase active site residues. Catalytic residues of RNase
L are depicted as pink sticks and IRE1 residues found at equivalent positions are colored beige.
Disordered regions are shown as dashed lines and the RNase L specific helix α1′ is shown in
red.
See also Figure S1 and Table S1.
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Figure 2. Structure of the pseudokinase domain of RNase L
(A) Ribbons view of the pseudo PK domain with non-canonical elements highlighted in red,
pink and magenta.
(B) Comparison of the structural topology of RNase L to the prototypical protein kinase PKA.
PKA activation segment, helix αEF and αEF-αF loop are colored green.
(C) Ribbons view of the kinase active site region of RNase L coloured as in (A). Corresponding
IRE1 residues are shown as green sticks.
(D) Residues that compose the catalytic (C) and regulatory (R) spines of RNase L are shown
as sticks with transparent surface. Binding of nucleotide to the kinase active site correlates with
the intact regulatory and catalytic spines.
See also Figure S2.
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Figure 3. Cross protomer interactions of the RNase L dimer
(A) Back-to-back interaction of the dual pseudo PK–RNase domain module. Right panels show
zoom in view of boxed regions.
(B) In trans interaction of the ANK domain with the pseudo PK domain. Bottom panels show
zoom in view of the boxed regions.
See also Figure S3.
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Figure 4. Composite binding site of the 2-5A activator
(A) Surface view of the RNase L dimer highlighting the outward facing channel that
accommodates 2-5A activators with length greater than 3 adenosine residues.
(B) Ribbons view of the composite binding site for the 2-5A activator (shown as sticks).
Interacting residues are shown in the zoom in view as sticks with transparent surface.
See also Figures S4 and S5.
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Figure 5. In vitro functional characterization of RNase L
(A) Binding of 2-5A to full length RNase L and isolated RNase L ANK domain assessed by
surface plasmon resonance. Response levels for specific binding of the indicated RNase L
forms to immobilized biotinylated 2-5A were plotted against increasing protein concentration
using, where appropriate, a variable slope model to determine the Hill coefficient and Kd.
Reported Kd is the average of two independent experiments +/− s.d. Displayed results are
representative of two independent experiments.
(B) RNase L activity profiles monitored in the indicated presence/absence of 2-5A activator
and 50μM of the indicated nucleotide using a FRET pair labeled RNA substrate. Displayed
results are representative of two independent experiments measured in duplicate (+/− s.e.m.).
(C) Binding of fluorescently labeled ATP analogue (BODIPY FL ATP-γ-S) to RNase L
assessed by monitoring the fluorescence polarization signal in the presence of increasing
concentrations of the indicated forms of RNase L. Displayed results are representative of two
independent experiments measured in duplicate (+/− s.e.m.).
(D-H) RNase activity profiles of wild type and the indicated mutant forms of RNase L
monitored as described in (B). Concentration of ADP in (D) was 2μM, and (E-H) was 50μM.
Displayed results are representative of two independent experiments measured in duplicate.
See also Figures S6 and S7.
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Figure 6. Functional analysis of RNase L in HeLa-M cells
(A-B) Effect of RNase L mutations on RNase activity. Cells were transfected with empty vector
or with plasmids expressing WT or the indicated mutant porcine RNase L. After 24 hrs cells
were transfected with poly(rI):poly(rC) (pIC) for 3 hrs. RNA was extracted from a fraction of
cells and separated on RNA chips. Western blots were performed on the cell extracts with anti-
FLAG antibody for detection of recombinant porcine RNase L and with anti-β-actin antibody.
(C-D) Effect of RNase L mutations on viral infections. HeLa-M cells transfected with plasmids
encoding WT or mutant forms of porcine RNase L were infected with EMCV for 14 hrs (see
Methods). Viral yields were determined by plaque assays on L929 indicator cells. Data are
shown as the mean ± standard deviation (SD) from three biological replicates. ***, p<0.001;
**p<0.01 * p<0.05; ns, not significant [when each group was compared to empty vector control
(Vector) with two-tailed Student's t-test].
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Figure 7. Regulation of RNase L by 2-5A and nucleotide binding
(A) Small angle x-ray scattering analysis of the 2-5A induced RNase L dimer in the presence
and absence of ADP (see Table S2 for data collection statistics). Top panels display the abinitio
calculated molecular envelopes. Bottom panels show envelopes with superimposed RNase L
crystal coordinates.
(B) Schematic of RNase L regulation by 2-5A and nucleotide binding. 2-5A binding to RNase
L through direct contact with the ANK domain and kinase N-lobe mediates molecular
dimerization while nucleotide binding to the kinase domain restrains the kinase domain to a
single closed conformation required for the composition of the RNase active site.
See also Table S2.
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